The molecular events that occur during early esophageal
Research gap analysis derived from 3 biology papers in our local library.
The gap
The molecular events that occur during early esophageal carcinogenesis are not well understood. Systematic molecular characterization of early human ESCC precursor lesions remains challenging. There is a need to better understand the molecu
Evidence profile
Sourced from the stated research gap and abstract of the source papers, classified as general, spanning 2 journals.
Research trend
Established — well-defined area with open sub-problems.
Supporting evidence — 3 representative gaps
- Temporal Transcriptomic Profiling of NMBA-Induced Rat Esophageal Squamous Carcinogenesis Identifies Early Inflammatory Activation and Late NRF2-Associated Oxidative-Stress Remodeling (2026) · International Journal of Molecular Sciences · doi
The molecular events that occur during early esophageal carcinogenesis are not well understood. Systematic molecular characterization of early human ESCC precursor lesions remains challenging. There is a need to better understand the molecular events that occur during early esophageal carcinogenesis to inform prevention, early detection, and mechanism-based intervention.
generalstated research gapKeywords: molecular events occur during early esophageal carcinogenesis well - PD04.03. SMYD2 as a Novel Molecular Regulator of Immune Evasion and Immunosuppression in Esophagogastric Junction Cancer (2026) · Diseases of the Esophagus · doi
Abstract Topic Esophageal Cancer: Molecular Biology/Pathology Background Immune checkpoint inhibitors targeting PD-1/PD-L1 have caused a paradigm shift in esophageal and gastric cancer treatment; however, oncogenic mechanisms regulating immune evasion and Treg-mediated immunosuppression remain unclear.
generalabstractevidence 5/5Keywords: esophageal cancer immune abstract topic molecular biology pathology background checkpoint inhibitors targeting caused paradigm shift - P1.074. SNORD33-Driven 18S rRNA 2′-O-Methylation Licenses TNFSF9–4-1BB Signaling and Sensitizes ESCC to PD-1 Blockade (2026) · Diseases of the Esophagus · doi
Abstract Topic Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies Background Neoadjuvant PD-1/PD-L1 based immunotherapy improve outcomes for resectable esophageal squamous cell carcinoma (ESCC), but patient outcome are heterogeneous and robust pretreatment blood biomarkers are lacking.
generalabstractevidence 5/5Keywords: esophageal adjuvant abstract topic cancer therapies background neoadjuvant based immunotherapy improve outcomes resectable squamous cell
Questions about this gap
Explore this gap further
Run this gap as a query across open scholarly engines for the latest related literature.
Working on this gap? Review it with us.
Science AI Journal reviews manuscripts in one pass with 8 specialised AI agents calibrated on 69,000+ real peer reviews.
Tools for your next paper
Related gaps in Biology
- Workshop participants agreed on the need for empiricalWorkshop participants agreed on the need for empirical research on areas in which data are lacking, including potential invasive species, na…
- The study identifies technical noise or insufficientThe study identifies technical noise or insufficient depth as a methodological vulnerability in the dataset. The study also mentions the cha…
- Stressing that justice entails far more than simplyStressing that justice entails far more than simply retribution, and underscoring that the relationship between criminal trials and peace re…
- The study identifies a gap in understandingThe study identifies a gap in understanding the principles governing the variability in the outcomes of interactions between environmental e…